• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据美国的种族/民族差异,透明细胞转移性肾细胞癌患者与基于人群的对照组之间的总生存率差异。

Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States.

机构信息

Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Goethe University Frankfurt, University Hospital Frankfurt, Department of Urology, Germany.

Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.

出版信息

Ann Epidemiol. 2023 Mar;79:65-70. doi: 10.1016/j.annepidem.2023.01.003. Epub 2023 Jan 11.

DOI:10.1016/j.annepidem.2023.01.003
Abstract

PURPOSE

To quantify differences in five-year overall survival (OS) between clear cell metastatic renal cell carcinoma (ccmRCC) patients and age- and sex-matched population-based controls, especially when race/ethnicity is considered.

METHODS

We relied on the Surveillance, Epidemiology and End Results database (2006-2016) to identify newly diagnosed (2006- 2011) ccmRCC patients of either Caucasian, Hispanic, African American, or Asian/Pacific Islander race/ethnicity. For each case, we simulated an age- and sex-matched control (Monte Carlo simulation), relying on Social Security Administration Life Tables with five-year follow-up. We compared OS between ccmRCC patients and controls. Multivariable Cox regression models tested for race/ethnicity effect on OS.

RESULTS

Of 3067 ccmRCC patients, 2167 (71%) were Caucasians vs. 488 (16%) Hispanics vs. 216 (7%) African Americans and 196 (6%) Asians/Pacific Islanders. At five years, OS difference between ccmRCC patients vs. population-based controls was greatest in African Americans (11 vs. 94%, Δ = 84%), followed by Hispanics (16 vs. 94%, Δ = 77%), Caucasians (16 vs. 89%, Δ = 73%) and Asians/Pacific Islanders (19 vs. 88%, Δ = 70%). In multivariable Cox regression models, African Americans exhibited highest Hazard Ratio for death (HR 1.3, p= 0.003).

CONCLUSION

Relative to Life Tables' derived age- and sex-matched controls, ccmRCC patients exhibit drastically worse OS, especially African Americans.

摘要

目的

量化透明细胞转移性肾细胞癌(ccmRCC)患者与年龄和性别匹配的基于人群对照者之间五年总生存率(OS)的差异,特别是考虑到种族/民族差异时。

方法

我们依赖于监测、流行病学和最终结果数据库(2006-2016 年),以确定白人、西班牙裔、非裔美国人和亚洲/太平洋岛民种族/民族的新诊断(2006-2011 年)ccmRCC 患者。对于每个病例,我们依赖社会安全管理局生命表进行了五年的随访,模拟了年龄和性别匹配的对照者(蒙特卡罗模拟)。我们比较了 ccmRCC 患者和对照者的 OS。多变量 Cox 回归模型测试了种族/民族对 OS 的影响。

结果

在 3067 例 ccmRCC 患者中,2167 例(71%)为白人,488 例(16%)为西班牙裔,216 例(7%)为非裔美国人,196 例(6%)为亚洲/太平洋岛民。在五年时,ccmRCC 患者与基于人群的对照者之间的 OS 差异在非裔美国人中最大(11% vs. 94%,Δ=84%),其次是西班牙裔(16% vs. 94%,Δ=77%)、白种人(16% vs. 89%,Δ=73%)和亚洲/太平洋岛民(19% vs. 88%,Δ=70%)。在多变量 Cox 回归模型中,非裔美国人的死亡风险比(HR)最高(1.3,p=0.003)。

结论

与生命表推导的年龄和性别匹配对照者相比,ccmRCC 患者的 OS 明显更差,尤其是非裔美国人。

相似文献

1
Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States.根据美国的种族/民族差异,透明细胞转移性肾细胞癌患者与基于人群的对照组之间的总生存率差异。
Ann Epidemiol. 2023 Mar;79:65-70. doi: 10.1016/j.annepidem.2023.01.003. Epub 2023 Jan 11.
2
Survival of stage III non-seminoma testis cancer patients versus simulated controls, according to race/ethnicity.根据种族/民族,III期非精原细胞瘤睾丸癌患者与模拟对照组的生存率。
Int J Urol. 2024 Oct;31(10):1137-1143. doi: 10.1111/iju.15532. Epub 2024 Jul 5.
3
Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinoma.种族/族裔对手术治疗的中/高风险非转移性透明细胞肾细胞癌患者生存的影响。
J Surg Oncol. 2024 Dec;130(8):1683-1690. doi: 10.1002/jso.27795. Epub 2024 Aug 25.
4
Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicity.转移性肾细胞癌的其他原因死亡率和获得治疗的机会与种族/民族有关。
Urol Oncol. 2022 Nov;40(11):493.e9-493.e16. doi: 10.1016/j.urolonc.2022.06.022. Epub 2022 Jul 27.
5
Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma.在转移性肾细胞癌中,非裔美国人种族对癌症特异性死亡率的影响因透明细胞与非透明细胞组织学亚型而异。
Cancer Epidemiol. 2018 Jun;54:112-118. doi: 10.1016/j.canep.2018.04.006. Epub 2018 May 16.
6
Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity.根据种族/民族划分的转移性透明细胞肾细胞癌的当代与历史生存率
World J Urol. 2022 Dec;40(12):2971-2978. doi: 10.1007/s00345-022-04183-0. Epub 2022 Oct 12.
7
Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities.根据不同的治疗方式,当代转移性肾细胞癌患者的生存存在种族和民族差异。
Cancer Causes Control. 2020 Mar;31(3):263-272. doi: 10.1007/s10552-020-01270-8. Epub 2020 Jan 28.
8
Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients.种族/族裔决定接受手术治疗的T1aN0M0期肾细胞癌患者的预期寿命。
Eur Urol Focus. 2022 Jan;8(1):191-199. doi: 10.1016/j.euf.2021.02.004. Epub 2021 Feb 18.
9
Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity.根据种族/民族划分的转移性尿路上皮膀胱癌患者的预期寿命。
Int Urol Nephrol. 2022 Jul;54(7):1521-1527. doi: 10.1007/s11255-022-03221-5. Epub 2022 May 4.
10
Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study.转移性非透明细胞肾细胞癌患者细胞减灭性肾切除术后的生存情况:一项基于人群的研究。
Eur Urol Focus. 2019 May;5(3):488-496. doi: 10.1016/j.euf.2017.11.012. Epub 2017 Dec 8.

引用本文的文献

1
Life expectancy in rare histological prostate cancer subtypes.罕见组织学类型前列腺癌亚型的预期寿命。
Int J Cancer. 2025 Jun 15;156(12):2311-2319. doi: 10.1002/ijc.35323. Epub 2024 Dec 30.
2
Disulfideptosis-associated lncRNAs reveal features of prognostic, immune escape, tumor mutation, and tumor malignant progression in renal clear cell carcinoma.二硫键程序性细胞死亡相关长非编码 RNA 揭示了肾透明细胞癌中与预后、免疫逃逸、肿瘤突变和肿瘤恶性进展相关的特征。
Aging (Albany NY). 2024 Feb 8;16(4):3280-3301. doi: 10.18632/aging.205534.